Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer

Journal: Nature Communications

Published: 2018-04-24

DOI: 10.1038/s41467-018-04107-w

Affiliations: 20

Authors: 18

Go to article
Institutions FC
Department of Radiology, MSKCC, United States of America (USA) 0.14
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA) 0.11
Tokyo Medical University Hospital, Japan 0.11
Radiochemistry and Imaging Sciences Service, MSKCC, United States of America (USA) 0.09
Department of Radiology, Cornell University, United States of America (USA) 0.07
Department of Urology, Cornell University, United States of America (USA) 0.06
Human Oncology and Pathogenesis Program (HOPP), MSKCC, United States of America (USA) 0.06
Department of Medical Physics, MSKCC, United States of America (USA) 0.06
Skåne University Hospital in Lund, SUS, Sweden 0.05
Division of Oncology and Pathology, LU, Sweden 0.05
Molecular Pharmacology Program, MSKCC, United States of America (USA) 0.05
Department of Medicine, MSKCC, United States of America (USA) 0.04
Department of Surgery, MSKCC, United States of America (USA) 0.04
Medical Radiation Physics, LU, Sweden 0.03
Department of Clinical Sciences - Lund, LU, Sweden 0.03
Department of Laboratory Medicine, MSKCC, United States of America (USA) 0.01
Oxford Nuffield Department of Surgical Sciences (NDS), United Kingdom (UK) 0.01
Department of Translational Medicine, LU, Sweden 0.01

Return